Related Experiment Video
Updated: Jan 18, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Heart Failure and Stroke: A Narrative Review
Takehiro Katano1, Hitoshi Mori2, Satoshi Suda1
1Department of Neurology, Nippon Medical School, Tokyo 113-8602, Japan.
Insights
Heart failure (HF) and stroke are linked, increasing global health burdens. Understanding their complex relationship is vital for better patient outcomes and future research in cardiovascular and cerebrovascular diseases.
Area of Science:
- Cardiology and Neurology
- Geriatric Medicine
- Public Health
Background:
- The global aging population is experiencing a rise in heart failure (HF) cases, termed the HF pandemic.
- HF is significantly linked to both ischemic and hemorrhagic stroke, exacerbating the global burden of cerebrovascular disease.
- Atrial fibrillation (AF) frequently coexists with HF, increasing the risk of ischemic stroke.
Purpose of the Study:
- To comprehensively review the pathophysiological and clinical interrelationship between heart failure and stroke.
- To provide updated insights for future research and clinical management of these interconnected conditions.
- To highlight the importance of understanding the HF-stroke connection in the context of a growing elderly population.
Main Methods:
- Literature review synthesizing current research on HF and stroke.
- Analysis of pathophysiological mechanisms linking cardiac and cerebrovascular events.
- Examination of clinical data and epidemiological trends.
Main Results:
- Heart failure and stroke share common risk factors and pathophysiological pathways.
- The prevalence of both conditions is increasing globally, particularly in aging populations.
- Effective management of HF, including "Fantastic Four" therapies for heart failure with reduced ejection fraction (HFrEF), may impact stroke risk.
Conclusions:
- A deeper understanding of the interplay between HF and stroke is essential for improving patient care.
- Further research is needed to elucidate specific mechanisms and develop targeted interventions.
- Integrated clinical management strategies are crucial for addressing the dual burden of HF and stroke.
Abstract:
The global aging population has led to a growing prevalence of heart failure (HF), signaling a new era often referred to as the HF pandemic. HF is strongly associated with both ischemic and hemorrhagic stroke, contributing to the global burden of cerebrovascular disease. In particular, ischemic stroke is frequently observed in patients with HF due to the common coexistence of atrial fibrillation (AF). Given that stroke and HF are both major causes of morbidity and mortality worldwide, a comprehensive understanding of their interrelationship is essential. In 2021, HF was redefined as "a clinical syndrome characterized by symptoms and signs resulting from structural and/or functional cardiac abnormalities, accompanied by current or prior evidence of elevated natriuretic peptides and/or objective findings of pulmonary or systemic congestion," and it is now classified according to ejection fraction. Among these categories, heart failure with reduced ejection fraction (HFrEF) has been the focus of extensive research, and its treatment has significantly advanced with the development of the so-called "Fantastic Four" pharmacologic therapies. A deeper understanding of the pathophysiological interplay between HF and stroke is crucial to inform future research and improve clinical practice. This review aims to comprehensively summarize the pathophysiological and clinical interrelationship between heart failure and stroke and to provide updated insights for future research and clinical management.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers
Heart Failure IV: Classification and Diagnostic Evaluation

